Doctor ZHOU specializes in gastrointestinal tumors, proficient in cellular therapy, molecular targeted therapy, and immunotherapy for gastric cancer, colorectal cancer, and hepatobiliary and pancreatic malignancies, as well as clinical research on new anti-tumor drugs. Conducted over 30 phase I-III clinical trials as a Principal Investigator (PI) or Sub-Investigator (Sub-I) for anti-tumor drugs. He is one of the earliest PIs in China to conduct CAR-T, CAR-NK, and TIL cell therapy for GI tumors.
